Chairs: Eduardo Richardet and Feliciano Barrón
Round Table 1: Early Stage Lung Cancer: Adjuvant Treatment
Coordinator (Facilitator): Norma Pilnik and Edgardo S. Santos
Round Table 2: Novel Approaches in Surgery. Robotic Surgery, Vats, Navigation System
Coordinator (Facilitator): Francisco Tarrazzi and Ricardo Santos
Round Table 3: Treatment of Wild Type Lung Cancer Tumors. First and Second Line
Coordinator (Facilitator): Paul A. Bunn, Jr., Eduardo Richardet and Carlos Carracedo
Round Table 4: Therapy of Tumors Carrying EGFR Mutations
Coordinator (Facilitator): Giorgio Scagliotti, Rafael Rosell and Luis Corrales-Rodriguez
Round Table 5: ALK Positive Tumors
Coordinator (Facilitator): Ticiana Leal and Christian Caglievic
Round Table 6: How to Study Molecular Biology and Tumor Markers
Coordinator (Facilitator): Fred R. Hirsch and Liliana Dalurzo
Round Table 7: New Molecules and Therapies for Lung Cancer
Coordinator (Facilitator): David R. Gandara, Claudio Martin and Oscar G. Arrieta
Round Table 8: Oligometastatic Lung Cancer
Coordinator (Facilitator): Delvys Rodriguez-Abreu, Beatriz Amendola and William William
Round Table 9: Diagnosis and Staging in Lung Cancer
Coordinator (Facilitator): Mark Block and Luis Ubillos
Round Table 10: Locally Advanced Lung Cancer
Coordinator (Facilitator): Ana Botero, Luis Alberto Mas Lopez, Nise Yamaguchi and Puneeth Iyengar
Round Table 11: Immunotherapy in Non-Small Lung Cancer
Coordinator (Facilitator): Clarissa Mathias, Luis E. Raez and Ignacio Gil-Bazo
Round Table 12: Liquid Biopsy
Coordinator (Facilitator): Christian Diego Rolfo, Alejandro Aviles and Marileila Varella-Garcia
Round Table 13: Uncommon Oncology Drivers: ROS1, BRAF, NTRK, MMR, RET
Coordinator (Facilitator): Jorge Gomez and Alberto Chiappori
Round Table 14: Small Cell Lung Cancer
Coordinator (Facilitator): Narjust Duma, Feliciano Barrón and Gelenis Calzadilla Domingo
Round Table 15: Pain Management and Palliative Care
Coordinator (Facilitator): Camilla Zimmerman, Silvia Allende and Saul Campos
Round Table 16: Management of Patients Who Has Failed Targeted Therapy or Immunotherapy - What We Do Next? What Is Coming?
Coordinator (Facilitator): Heather Wakelee